Mesoblast Ltd - ADR

NASDAQ:MESO  
15.62
+3.28 (+26.58%)
7:59:18 PM EDT: $15.82 +0.20 (+1.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.00B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$15.58 Million
Adjusted EPS-$0.40
See more estimates
10-Day MA$12.05
50-Day MA$11.32
200-Day MA$12.75
See more pivots

Mesoblast Ltd - ADR Stock, NASDAQ:MESO

55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000
Australia
Phone: +61.3.9639.6036
Number of Employees: 73

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.